Literature DB >> 20709160

Expression of the nuclear transport protein importin ß-1 and its association with the neurokinin 3 receptor in the rat hypothalamus following acute hyperosmotic challenge.

D D Jensen1, K Sundstrom, F W Flynn.   

Abstract

The tachykinin NK3 receptor (NK3R) is a G-protein coupled receptor that is activated, internalized, and trafficked to the nuclei of magnocellular neurons in the paraventricular nucleus of the hypothalamus (PVN) in response to acute hyperosmolarity. The lack of information on the nuclear import pathway raises concerns about the physiological role of nuclear NK3R. NK3R contains a nuclear localizing sequence (NLS) and this raises the possibility that importins are involved in transport of NK3R through the nuclear pore complex. The following experiments utilized: (1) co-immunoprecipitation to determine if NK3R is associated with importin ß-1 following activation in response to acute hyperosmolarity in vivo, and (2) immuno-neutralization of importin ß-1 in vitro to determine if nuclear transport of NK3R was blocked. Rats were given an i.v. injection of hypertonic saline (2 M) and 10 min after the infusion, the PVN was removed and homogenized. Importin ß-1 co-immunoprecipitated with the NK3R following treatment with 2 M NaCl, but not following isotonic saline treatment. Immuno-neutralization of importin ß-1 decreased the transport of NK3R into the nuclei in a time dependent fashion. The results indicate that in response to acute hyperosmotic challenge, NK3R associates with importin ß-1 which enables the nuclear transport of NK3R. This is the first in vivo study linking importin ß-1 and the nuclear transport of a G protein coupled receptor, the NK3R, in brain.
Copyright © 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20709160      PMCID: PMC2949499          DOI: 10.1016/j.neuroscience.2010.08.015

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  40 in total

Review 1.  Nuclear targeting of proteins: how many different signals?

Authors:  D Christophe; C Christophe-Hobertus; B Pichon
Journal:  Cell Signal       Date:  2000-05       Impact factor: 4.315

2.  Specificity controls for immunocytochemical methods.

Authors:  R W Burry
Journal:  J Histochem Cytochem       Date:  2000-02       Impact factor: 2.479

Review 3.  Trafficking and signaling pathways of nuclear localizing protein ligands and their receptors.

Authors:  Howard M Johnson; Prem S Subramaniam; Sjur Olsnes; David A Jans
Journal:  Bioessays       Date:  2004-09       Impact factor: 4.345

4.  Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry.

Authors:  Clifford B Saper; Paul E Sawchenko
Journal:  J Comp Neurol       Date:  2003-10-13       Impact factor: 3.215

Review 5.  Peptide immunocytochemistry.

Authors:  L I Larsson
Journal:  Prog Histochem Cytochem       Date:  1981

6.  A short amino acid sequence able to specify nuclear location.

Authors:  D Kalderon; B L Roberts; W D Richardson; A E Smith
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

7.  Neurokinin release in the rat nucleus of the solitary tract via NMDA and AMPA receptors.

Authors:  I Colin; C Blondeau; A Baude
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

Review 8.  G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm.

Authors:  Fernand Gobeil; Audrey Fortier; Tang Zhu; Michela Bossolasco; Martin Leduc; Michel Grandbois; Nikolaus Heveker; Ghassan Bkaily; Sylvain Chemtob; David Barbaz
Journal:  Can J Physiol Pharmacol       Date:  2006 Mar-Apr       Impact factor: 2.273

9.  Transcriptional activation and nuclear targeting signals of the human androgen receptor.

Authors:  J A Simental; M Sar; M V Lane; F S French; E M Wilson
Journal:  J Biol Chem       Date:  1991-01-05       Impact factor: 5.157

10.  Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors.

Authors:  Dennis K Lee; A José Lança; Regina Cheng; Tuan Nguyen; Xiao Dong Ji; Fernand Gobeil; Sylvain Chemtob; Susan R George; Brian F O'Dowd
Journal:  J Biol Chem       Date:  2003-11-26       Impact factor: 5.157

View more
  7 in total

1.  Characterization of nuclear neurokinin 3 receptor expression in rat brain.

Authors:  C D Sladek; W Stevens; S R Levinson; Z Song; D D Jensen; F W Flynn
Journal:  Neuroscience       Date:  2011-09-08       Impact factor: 3.590

Review 2.  Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.

Authors:  Martin S Steinhoff; Bengt von Mentzer; Pierangelo Geppetti; Charalabos Pothoulakis; Nigel W Bunnett
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

Review 3.  Diverse roles of G-protein coupled receptors in the regulation of neurohypophyseal hormone secretion.

Authors:  C D Sladek; Z Song
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

4.  Neurokinin 3 receptor forms a complex with acetylated histone H3 and H4 in hypothalamic neurons following hyperosmotic challenge.

Authors:  Francis W Flynn; Dane D Jensen; Amit Thakar; Xihui Xu; Steven W Flynn; Zhaojie Zhang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-22       Impact factor: 3.619

5.  Neurokinin B induces c-fos transcription via protein kinase C and activation of serum response factor and Elk-1 in immortalized GnRH neurons.

Authors:  Christine A Glidewell-Kenney; Crystal Trang; Paul P Shao; Navarre Gutierrez-Reed; Adaku M Uzo-Okereke; Djurdjica Coss; Pamela L Mellon
Journal:  Endocrinology       Date:  2014-07-24       Impact factor: 4.736

6.  Activation of tachykinin, neurokinin 3 receptors affects chromatin structure and gene expression by means of histone acetylation.

Authors:  Amit Thakar; Elise Sylar; Francis W Flynn
Journal:  Peptides       Date:  2012-09-15       Impact factor: 3.750

7.  Lemur Tyrosine Kinase 2, a novel target in prostate cancer therapy.

Authors:  Kalpit Shah; Neil A Bradbury
Journal:  Oncotarget       Date:  2015-06-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.